Cefadroxil as Oral Transitional Therapy for Gram-Positive Bacteremia With or Without Non-Vertebral Osteomyelitis: A Multicenter Retrospective Cohort Study

By afschroeder • August 12, 2026

Clark DC, Baden R, Banerjee J, Bedrossian R, Chute H, Davar K, Deng D, Donnelly M, Fernandez D, Goodman R, Gordon H, Harris E, Hutcheon D, Jeng A, Kolluru V, Lee P, Martinez E, Miller LG, Minejima E, Mykhaylov V, Perez M, Russell D, Srinivasa V, Syed I, Wald-Dickler N, Spellberg B, Freling SR. Cefadroxil as Oral Transitional Therapy for Gram-Positive Bacteremia With or Without Non-Vertebral Osteomyelitis: A Multicenter Retrospective Cohort Study. Open Forum Infect Dis. 2026 Aug 10;13(8):ofag413. doi: 10.1093/ofid/ofag413. PMID: 42577802; PMCID: PMC13455355.

Tags: Harbor UCLA, Infectious Diseases, Olive View DoM, Publications

Renal Outcomes of Triglyceride-Targeting Lipid-Lowering Therapies versus Statins in Patients with CKD

Naim MAAZ, Thomas F, Streja E, Davis RL, Kalantar-Zadeh K, Sumida K, Kovesdy CP. Renal Outcomes of Triglyceride-Targeting Lipid-Lowering Therapies versus Statins in Patients with[...]

A Review of Randomized Controlled Trials for Vitiligo Therapies Published Between 2013 and 2023

Maverakis Ramirez N, Jaeger ZJ, Lee DJ. A Review of Randomized Controlled Trials for Vitiligo Therapies Published Between 2013 and 2023. Cureus. 2026 Jul 8;18(7):e112280.[...]

Proteomic Mediators of Chronic Obstructive Pulmonary Disease Phenotypes and Coronary Artery Calcification Burden in Ever Smokers

Abbasi A, Ahmad K, Pratte KA, Moore J, DeMeo DL, Manubolu VS, Kinninger A, Tiller NB, Bowler RP, Budoff M, Casaburi R, Rossiter HB. Proteomic[...]